|10.24||+0.46 / +4.70%|
Data as of 4:00pm ET
|10.26||+0.02 / +0.20%|
The 8 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 13.25, with a high estimate of 18.00 and a low estimate of 4.00. The median estimate represents a +29.39% increase from the last price of 10.24.
The current consensus among 8 polled investment analysts is to Buy stock in Solazyme Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.